Highly sensitive lens culinaris agglutinin-reactive α-fetoprotein is useful for early detection of hepatocellular carcinoma in patients with chronic liver disease

Oncology Reports

Volumn 26, Issue 5, 2011, Pages 1227-1233

  Oda, Kohei ^a   Ido, Akio ^a   Tamai, Tsutomu ^a   Matsushita, Masakaze ^b   Kumagai, Kotaro ^a   Mawatari, Sei Ichi ^a   Saishoji, Akiko ^a   Kure, Takeshi ^a   Ohno, Kaori ^a   Toyokura, Eriko ^a   Imanaka, Dai ^a   Moriuchi, Akihiro ^a   Uto, Hirofumi ^a   Oketani, Makoto ^a   Hashiguchi, Teruto ^b   Tsubouchi, Hirohito ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b KAGOSHIMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

fetoprotein; fetoprotein fucosylated fraction L3; Hepatocarcinogenesis; Hepatocellular carcinoma

Indexed keywords

ALPHA FETOPROTEIN; PLANT LECTIN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CANCER STAGING; CHILD; CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; LENTIL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SENSITIVITY AND SPECIFICITY; TUMOR DIFFERENTIATION;

AGED; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LIVER DISEASES; LIVER NEOPLASMS; MALE; MIDDLE AGED; PLANT LECTINS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 80053158728     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1425     Document Type: Article

References (27)

1. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statics. 2002. CA Cancer J Clin 55: 74-108, 2005.
2. El-Serag HB and Masson AC: Rising incidence of hepatocellular carcinoma in the United States. N Eng J Med 340: 745-750, 1999. (Pubitemid 29114292)
3. Oka H, Tamori A, Kuroki T, Kobayashi K and Yamamoto S: Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma. Hepatology 19: 61-66, 1994.
4. Ishii M, Gama H, Chida N, Ueno Y, Shinzawa H, Takagi T, Toyota T, Takahashi T and Kasukawa R: Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group. Am J Gastroenterol 85: 1036-1040, 2000. (Pubitemid 30196743)
5. Okuda H, Nakanishi T, Takatsu K, Saito A, Hayashi N, Takasaki K, Takenami K, Yamamoto M and Nakano M: Serum levels des-gamma-carboxy prothrombin measured using the revised enzyme immunoassay kit with increased sensitivity in relation to clinicopathologic features of solitary hepatocellulat carcinoma. Cancer 88: 544-549, 2000. (Pubitemid 30056927)
6. Grazi GL, Mazziotti A, Legnani C, Jovine E, Miniero R, Gallucci A, Palareti G and Gozzetti G: The role of tumor markers in the diagnosis of hepatocellular carcinoma, with special reference to ethe des-gamma-carboxy prothrombin. Liver Transpl Surg 1: 249-255, 1995.
7. Wang CS, Lin CL, Lee HC, Chen KY, Chiang MF, Chen HS, Lin TJ and Liao LY: Usefulness of serum des-gamma-carboxy prothrombin in detection of hepatocellular carcinoma. World J Gastroenterol 11: 6115-6119, 2005.
8. Marrero JA, Su GL, Wei W, Emick D, Conjeevaram HS, Fontana RJ and Lok AS: Des-gammma carboxy prothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in American patients. Hepatology 37: 1114-1121, 2003. (Pubitemid 36538688)
9. Taketa K: Alpha-fetoprotein: reevaluation in hepatology. Hepatology 12: 1420-1432, 1999.
10. Taketa K, Okada S, Win N, Hlaing NK and Wind KM: Evaluation of tumor markers for the detection of hepatocellular carcinoma in Yangon General Hospital, Myanmar. Acta Med Okayama 56: 317-320, 2002. (Pubitemid 135690298)
11. Khien VV, Mao HV, Chinh TT, Ha PT, Bang MH, Lac BV, Hop TV, Tuan NA, Don LV, Taketa K and Satomura S: Clinical evaluation of lentil lectin-reactive alpha-fetoprotein-L3 in histology-proven hepatocellular carcinoma. Int J Biol Markers 16: 105-111, 2001. (Pubitemid 32755127)
12. Oka H, Saito A, Ito K, Kumada T, Satomura S, Kasugai H, Osaki Y, Seki T, Kudo M and Tanaka M: Collaborative Hepato-Oncology Study Group of Japan. Multicenter prospective analysis of newly diagnosed hepatocellular carcinoma with respect or the percentage of Lens culinaris agglutinin-reactive alpha-fetoprotein. J Gastroenterol Hepatol 16: 1378-1383, 2001. (Pubitemid 34107406)
13. Nakamura K, Imajo N, Yamagata Y, Katoh H, Fujio K, Tanaka T, Satomura S and Matsuura S: Liquid-phase binding assay of alpha-fetoprotein using a sulfated antibody for bound/free separation. Anal Chem 70: 954-957, 1998.
14. Kawabata T, Wada HG, Watanabe M and Satomura S: Electrokinetic analyte transport assay for alpha-fetoprotein immunoassay integrates mixing, reaction and separation on-chip. Electropheresis. 29: 1399-1406, 2008. (Pubitemid 351524351)
15. Kagebayashi C, Yamaguchi I, Akinaga A, Kitano H, Yokoyama K, Satomura M, Kurosawa T, Watanabe M, Kawabata T, Chang W, Li C, Bousse L, Wada HG and Satomura S: Automated immunoassay system for AFP-L3% using on-chip electrokinetic reaction and separation by affinity electrophoresis. Anal Biochem 388: 306-311, 2009.
16. Liver Cancer Study Group of Japan: General Rules for the Clinical and Pathological Study of Primary Liver Cancer. English edition. Kanehara, Tokyo, 2003.
17. Kudo M, Chung H and Osaki Y: Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score). J Gastroenterol 38: 207-215, 2003. (Pubitemid 36527122)
18. Toyoda H, Kumada T, Tada T, Kaneoka Y, Maeda A, Kanke F and Satomura S: Clinical utility of highly sensitive lens culinaris agglutinin-reactive alpha-fetoprotein in hepatocellular carcinoma patients with alpha fetoprotein <20 ng/ml. Cancer Sci 102: 1025-1031, 2011.
19. Ikeda K, Saitoh S, Koida K, Tsubota A, Arase Y, Chayama K and Kumada H: Diagnosis and follow-up of small hepatocellular carcinoma with selective intraarterial digital subtraction angiography. Hepatology 17: 1003-1007, 1993. (Pubitemid 23187403)
20. Takayasu K, Moriyama N, Muramatsu Y, Makuuchi M, Hasegawa H, Okazaki N and Hirohashi S: The diagnosis of small hepatocellular carcinomas: efficacy of various imaging procedures in 100 patients. Am J Roentgenol 155: 49-54, 1990. (Pubitemid 20218673)
21. Takayasu K, Furukawa H, Wakao F, Muramatsu Y, Abe H, Terauchi T, Winter TC 3rd, Sakamoto M and Hirohashi S: CT diagnosis of early hepatocellular carcinoma: sensitivity, findings, and CT-pathologic correlation. Am J Roentgenol 164: 885-890, 1995.
22. Tamura Y, Igarashi M, Kawai H, Suda T, Satomura S and Aoyagi Y: Clinical advantage of highly sensitive on-chip immunoassay for fucosylated fraction of alpha-fetoprotein in patients with hepatocellular carcinoma. Dig Dis Sci 55: 3576-3583, 2010.
23. Hanaoka T, Sato S, Tobita H, Miyake T, Ishihara S, Akagi S, Amano Y and Kinoshita Y: Clinical significance of high sensitive fucosylated fraction of alpha-fetoprotein in patients with chronic liver disease. J Gastroenterol Hepatol 26: 739-744, 2011.
24. Taketa K, Endo Y, Sekiya C, Tanikawa K, Koji T, Taga H, Satomura S, Matsuura S, Kawai T and Hirai H: A collaborative study for the evaluation of lectin-reactive alpha-fetoprotein in early detection of hepatocellular carcinoma. Cancer Res 53: 5419-5423, 1993. (Pubitemid 23342160)
25. Kumada T, Nakano S, Takeda I, Kiriyama S, Sone Y, Hayashi K, Katoh H, Endoh T, Sassa T and Satomura S: Clinical utility of lens culinaris agglutinin-reactive alpha-fetoprotein in small hepatocellular carcinoma: special reference to imaging diagnosis. J Hepatol 30: 125-130, 1999. (Pubitemid 29023661)
26. Yoshida H, Shiratori Y, Moriyama M, Arakawa Y, Ide T, Sata M, Inoue O, Yano M, Tanaka M, Fujiyama S, Nishiguchi S, Kuroki T, Imazeki F, Yokosuka O, Kinoyama S, Yamada G and Omata M: Interferon therapy reduces the risk of hepatocellular carcinoma: national surveillance program of cirrhotic and non cirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy. Ann Intern Med 131: 174-181, 1999. (Pubitemid 29364999)
27. Tateyama M, Yatsuhashi H, Taura N, Motoyoshi Y, Nagaoka S, Yanagi K, Abiru S, Yano K, Komori A, Migita K, Nakamura M, Nagahama H, Sasaki Y, Miyakawa Y and Ishibashi H: Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virus. J Gastroenterol 46: 92-100, 2011.